Suppr超能文献

阻塞性睡眠呼吸暂停患者和非呼吸暂停打鼾者对鼻持续气道正压通气(CPAP)的长期依从性。

Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers.

作者信息

Krieger J

机构信息

Sleep Disorders Unit, University Hospital, Strasbourg, France.

出版信息

Sleep. 1992 Dec;15(6 Suppl):S42-6. doi: 10.1093/sleep/15.suppl_6.s42.

Abstract

In a prospective study aimed at evaluating objectively the compliance with nasal continuous positive airway pressure (CPAP) treatment, 233 obstructive sleep apnea (OSA) (apnea index, > 10 apneas/hour) patients and 36 nonapneic snorers were studied. The compliance to treatment was measured by the mean rate of use of the CPAP device, obtained from a built-in time counter. The follow-up period was 874 +/- 48 in OSA patients and 675 +/- 83 in snorers. CPAP was proposed to all OSA patients but only to those snorers who felt improved after an initial laboratory night on CPAP. Nineteen OSA patients refused CPAP. Of the 214 OSA patients who accepted CPAP, 181 are still on treatment, with a mean daily rate of use of 5.6 +/- 0.1 hours (mean +/- SEM); 22 patients stopped CPAP after a variable period of time; 10 patients died and one acromegalic patient was considered cured after hypophysectomy for a pituitary adenoma. Depending upon the definition of acceptable compliance, the compliance rate in this group was between 77% and 89%. The mean rate of use was correlated with indices of disease severity (apnea index, apnea+hypopnea index, minimal SaO2 during sleep, daytime PaO2, pulmonary artery pressure). Thirty-six nonapneic snorers accepted CPAP. In this group, 26 are still on CPAP, with a mean daily rate of use of 5.4 +/- 0.5 hours; one patient died; one underwent uvolopalatopharyngoplasty without follow-up; and eight stopped CPAP. The compliance rate in this group was between 58% and 78%. This study shows that CPAP is reasonably accepted by OSA patients as well as by nonapneic snorers.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在一项旨在客观评估鼻持续气道正压通气(CPAP)治疗依从性的前瞻性研究中,对233例阻塞性睡眠呼吸暂停(OSA)(呼吸暂停指数>10次/小时)患者和36例非呼吸暂停打鼾者进行了研究。治疗依从性通过内置时间计数器获得的CPAP设备平均使用速率来衡量。OSA患者的随访期为874±48天,打鼾者为675±83天。所有OSA患者均被建议使用CPAP,但仅对那些在初次实验室夜间使用CPAP后感觉症状改善的打鼾者建议使用。19例OSA患者拒绝使用CPAP。在接受CPAP的214例OSA患者中,181例仍在接受治疗,平均每日使用时长为5.6±0.1小时(均值±标准误);22例患者在不同时间段后停止使用CPAP;10例患者死亡,1例肢端肥大症患者在垂体腺瘤垂体切除术后被认为治愈。根据可接受依从性的定义,该组的依从率在77%至89%之间。平均使用速率与疾病严重程度指标(呼吸暂停指数、呼吸暂停+低通气指数、睡眠期间最低血氧饱和度、日间动脉血氧分压、肺动脉压)相关。36例非呼吸暂停打鼾者接受了CPAP。在该组中,26例仍在使用CPAP,平均每日使用时长为5.4±0.5小时;1例患者死亡;1例接受了悬雍垂腭咽成形术,未进行随访;8例停止使用CPAP。该组的依从率在58%至78%之间。这项研究表明,OSA患者和非呼吸暂停打鼾者对CPAP的接受程度较为合理。(摘要截选至250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验